The Tokyo Metropolitan Institute of Gerontology (TMIG) has been making progressive efforts in resolving problems brought about by the aged society since its inception in 1972. TMIG
was combined with the Tokyo Metropolitan Geriatric Hospital (TMGH) located on the same campus to start a new local incorporated administrative agency in April 2009.
In the research institute, as of April 2015, approximately 200 researchers, including 84 full-time employees, part-time employees, and graduate students, are engaged in research activities based on the medium-term goals approved by the Tokyo Metropolitan Assembly. The first medium-term goal (2009-2012) was to promote "research to support medicine and care for the elderly," which bore much fruit, and received a high evaluation from the Tokyo Metropolitan Local Incorporated Administrative Agency Evaluation Committee and the external evaluation committee affiliated with TMIG. As a result, researchers at the institute are especially ranked highly in terms of obtaining competitive research funding and their approval rate of new proposals by the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science and Technology for scientific research grants, thus enabling its research to remain active.
The 5-year medium-term goal (2013-2017) is to promote "research aiming to maintain and advance the elderly's health and improve their vitality." Since we moved to our new and long-awaited facilities in May 2013, we implemented new research equipment such as PET-CT and a super-resolution microscope to help achieve the medium-term goal. Moreover, we have launched new research agendas, i.e., "the early detection of dementia and the development of a system to train doctors and nurses" and "the development of various biomarkers associated with aging and senile diseases (or geriatric diseases)," and are steadily producing positive results.
The strongest point of TMIG is that we have researchers engaged in interdisciplinary research. They have backgrounds in biology, basic medicine, and pharmaceutics as well as in epidemiology, welfare, nursing care, and social sciences such as medical economics; we also have strong support of doctors, nurses, pharmacists, paramedics, and other health professionals. We would like to deepen our collaboration with TMGH to promote translational research, in order to prove that our research results can contribute to the advancement of clinical medicine and an improvement in the health of local residents.
As we are entering the super-aged society, there are many research agendas to be undertaken by our institute. All of us are daily working on our research in the new facilities with advanced research equipment. We always appreciate your continued instruction, encouragement, and support for TMIG.
Shunei Kyo, M.D., Ph.D.
President of Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology